241 related articles for article (PubMed ID: 32080807)
1. A high affinity nanobody against endothelin receptor type B: a new approach to the treatment of melanoma.
Ji L; Dong C; Fan R; Qi S
Mol Biol Rep; 2020 Mar; 47(3):2137-2147. PubMed ID: 32080807
[TBL] [Abstract][Full Text] [Related]
2. Microcystin-LR nanobody screening from an alpaca phage display nanobody library and its expression and application.
Xu C; Yang Y; Liu L; Li J; Liu X; Zhang X; Liu Y; Zhang C; Liu X
Ecotoxicol Environ Saf; 2018 Apr; 151():220-227. PubMed ID: 29353171
[TBL] [Abstract][Full Text] [Related]
3. [Construction of camelidae natural nanobody phage dispaly library and screening, production and identification of anti-CD19 nanobody].
Li G; Li Y; Chu Y; Zhang A; Pan J; Wang H; Xu G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1036-1043. PubMed ID: 33210599
[TBL] [Abstract][Full Text] [Related]
4. Recombinant λ bacteriophage displaying nanobody towards third domain of HER-2 epitope inhibits proliferation of breast carcinoma SKBR-3 cell line.
Shoae-Hassani A; Mortazavi-Tabatabaei SA; Sharif S; Madadi S; Rezaei-Khaligh H; Verdi J
Arch Immunol Ther Exp (Warsz); 2013 Feb; 61(1):75-83. PubMed ID: 23224340
[TBL] [Abstract][Full Text] [Related]
5. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
6. Selection and characterization of specific nanobody against bovine virus diarrhea virus (BVDV) E2 protein.
Li T; Huang M; Xiao H; Zhang G; Ding J; Wu P; Zhang H; Sheng J; Chen C
PLoS One; 2017; 12(6):e0178469. PubMed ID: 28582444
[TBL] [Abstract][Full Text] [Related]
7. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
[TBL] [Abstract][Full Text] [Related]
8. A Comparison Between Cell, Protein and Peptide-Based Approaches for Selection of Nanobodies Against CD44 from a Synthetic Library.
Kavousipour S; Mokarram P; Gargari SLM; Mostafavi-Pour Z; Barazesh M; Ramezani A; Ashktorab H; Mohammadi S; Ghavami S
Protein Pept Lett; 2018; 25(6):580-588. PubMed ID: 29848261
[TBL] [Abstract][Full Text] [Related]
9. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma.
Xia L; Teng Q; Chen Q; Zhang F
Int J Nanomedicine; 2020; 15():2197-2205. PubMed ID: 32280214
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of a human nanobody against VEGFR-2.
Ma L; Gu K; Zhang CH; Chen XT; Jiang Y; Melcher K; Zhang J; Wang M; Xu HE
Acta Pharmacol Sin; 2016 Jun; 37(6):857-64. PubMed ID: 27108602
[TBL] [Abstract][Full Text] [Related]
12. Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library.
Yan J; Wang P; Zhu M; Li G; Romão E; Xiong S; Wan Y
J Nanobiotechnology; 2015 May; 13():33. PubMed ID: 25944262
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary Study on Screening and Identification of Lewis a Antigen Mimic Epitope in Alpaca Phage Display Nanobody Library].
Zhong XL; Yang L; Zhang J; Sun LP; Ma MZ; Fan B; Shang W; Huang YS; Wang DQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):877-883. PubMed ID: 35680821
[TBL] [Abstract][Full Text] [Related]
14. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers.
Jovčevska I; Zupanec N; Kočevar N; Cesselli D; Podergajs N; Stokin CL; Myers MP; Muyldermans S; Ghassabeh GH; Motaln H; Ruaro ME; Bourkoula E; Turnšek TL; Komel R
PLoS One; 2014; 9(11):e113688. PubMed ID: 25419715
[TBL] [Abstract][Full Text] [Related]
15. Screening, Expression and Identification of Nanobody Against Monkeypox Virus A35R.
Meng N; Cheng X; Sun M; Zhang Y; Sun X; Liu X; Chen J
Int J Nanomedicine; 2023; 18():7173-7181. PubMed ID: 38076734
[TBL] [Abstract][Full Text] [Related]
16. A novel nanobody against urease activity of Helicobacter pylori.
Ardekani LS; Gargari SL; Rasooli I; Bazl MR; Mohammadi M; Ebrahimizadeh W; Bakherad H; Zare H
Int J Infect Dis; 2013 Sep; 17(9):e723-8. PubMed ID: 23561799
[TBL] [Abstract][Full Text] [Related]
17. Nanobodies targeting the interaction interface of programmed death receptor 1 (PD-1)/PD-1 ligand 1 (PD-1/PD-L1).
Wen B; Zhao L; Wang Y; Qiu C; Xu Z; Huang K; Zhu H; Li Z; Li H
Prep Biochem Biotechnol; 2020; 50(3):252-259. PubMed ID: 31799894
[TBL] [Abstract][Full Text] [Related]
18. Random mutagenesis of BoNT/E Hc nanobody to construct a secondary phage-display library.
Shahi B; Mousavi Gargari SL; Rasooli I; Rajabi Bazl M; Hoseinpoor R
J Appl Microbiol; 2014 Aug; 117(2):528-36. PubMed ID: 24766494
[TBL] [Abstract][Full Text] [Related]
19. A novel VHH nanobody against the active site (the CA domain) of tumor-associated, carbonic anhydrase isoform IX and its usefulness for cancer diagnosis.
Araste F; Ebrahimizadeh W; Rasooli I; Rajabibazl M; Mousavi Gargari SL
Biotechnol Lett; 2014 Jan; 36(1):21-8. PubMed ID: 24068505
[TBL] [Abstract][Full Text] [Related]
20. Construction of an alpaca immune antibody library for the selection of nanobodies against
Qiu J; Li J; Zhang Z; Dong S; Ling X; Fang Z; Ling Q; Huang Z
Front Bioeng Biotechnol; 2023; 11():1207048. PubMed ID: 37362207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
